Literature DB >> 35796820

Managing fibromyalgia with complementary and alternative medical exercise: a systematic review and meta-analysis of clinical trials.

Paraschou Vasileios1,2, Partalidou Styliani3,4, Gkekas Nifon5,6, Siolos Pavlos5,7, Fotiadis Aris8,9, Pantekidis Ioannis10,11.   

Abstract

Fibromyalgia is a chronic medical condition of unclear etiopathology that diminished patients' quality of life; chronic pain is the main symptom, yet patients with fibromyalgia struggle also with depression, anxiety, and insomnia. For many years, pharmaceutical management of pain was the mainstay of treatment. In the latest decade, conventional low-impact aerobic exercise and complementary and alternative medical (CAM) exercise have become important when structuring a personalized therapeutic plan, since side effects are practically inexistent. Heterogenous studies with different methodological approaches have failed to display a clear clinical effect. We conducted a systematic review with meta-analysis of clinical trials putting emphasis on standardized measurable outcomes (Fibromyalgia Impact Questionnaire, FIQ) in our effort to draw a safe conclusion on CAM exercise's effect. After analyzing 14 studies, including 886 patients, meta analysis showed CAM exercise had a beneficial effect on patients' FIQ score reports: standardized mean difference (SMD) 1.330 (95% CI 0.733-1.928). Among them, dance and Tai chi, had a more profound effect: SMD 1.969 (95% CI 0.575-3.364) and SMD 1.852 (95% CI 0.119-3.584), respectively. However, the risk of bias was overall medium to high and statistical heterogeneity was very high. Our meta-regression analysis failed to identify any variable that could account for high heterogeneity. Even though more experimental studies should be done on this subject, CAM exercise seems beneficial for patients with Fibromyalgia.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alternative medicine; Chronic pain; Complementary therapies; Fibromyalgia

Mesh:

Substances:

Year:  2022        PMID: 35796820     DOI: 10.1007/s00296-022-05151-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  39 in total

Review 1.  Epidemiology of fibromyalgia.

Authors:  Lily Neumann; Dan Buskila
Journal:  Curr Pain Headache Rep       Date:  2003-10

2.  Long-term evaluation of opioid treatment in fibromyalgia.

Authors:  Xiaomei Peng; Rebecca L Robinson; Philip Mease; Kurt Kroenke; David A Williams; Yi Chen; Douglas Faries; Madelaine Wohlreich; Bill McCarberg; Danette Hann
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

Review 3.  Role of inflammation in the pathogenesis and treatment of fibromyalgia.

Authors:  Ilke Coskun Benlidayi
Journal:  Rheumatol Int       Date:  2019-02-13       Impact factor: 2.631

4.  Preliminary Evidence of Increased Pain and Elevated Cytokines in Fibromyalgia Patients with Defective Growth Hormone Response to Exercise.

Authors:  Rebecca L Ross; Kim D Jones; Robert M Bennett; Rachel L Ward; Brian J Druker; Lisa J Wood
Journal:  Open Immunol J       Date:  2010

Review 5.  Central sensitization: implications for the diagnosis and treatment of pain.

Authors:  Clifford J Woolf
Journal:  Pain       Date:  2010-10-18       Impact factor: 6.961

6.  Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia.

Authors:  Frederick Wolfe; Kaleb Michaud; Tracy Li; Robert S Katz
Journal:  J Rheumatol       Date:  2010-01-15       Impact factor: 4.666

Review 7.  Fibromyalgia: a clinical review.

Authors:  Daniel J Clauw
Journal:  JAMA       Date:  2014-04-16       Impact factor: 56.272

8.  Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study.

Authors:  Roland Staud; Susann Nagel; Michael E Robinson; Donald D Price
Journal:  Pain       Date:  2009-06-21       Impact factor: 6.961

9.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

10.  Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective "real world" data analysis of fibromyalgia patients.

Authors:  Martin Offenbaecher; Niko Kohls; Thomas Ewert; Claudia Sigl; Robin Hieblinger; Loren L Toussaint; Fuschia Sirois; Jameson Hirsch; Miguel A Vallejo; Sybille Kramer; Javier Rivera; Gerold Stucki; Jörg Schelling; Andreas Winkelmann
Journal:  Rheumatol Int       Date:  2021-03-05       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.